Overview


According to FutureWise analysis the market for anatomic pathology track and trace solutions in 2023 is US$ 0.69 billion, and is expected to reach US$ 1.54 billion by 2031 at a CAGR of 10.52%.

Anatomic Pathology Track and Trace Solutions, also known as bar code-based tracking solutions, have recently found their way into anatomic pathology (AP) laboratories, paralleling their established presence in clinical pathology settings. These systems play a pivotal role in efficiently managing AP assets, encompassing specimens, blocks, and slides, while concurrently elevating laboratory performance, bolstering patient safety, and refining the quality of patient care. Moreover, the tracking of AP assets extends its utility beyond the laboratory by facilitating the routing of surplus clinical material into research laboratories and biorepositories, thereby contributing to scientific advancements and medical research. However, the implementation of such tracking solutions is far from a plug-and-play endeavor. Not all tracking solutions are created equal, necessitating a meticulous assessment of laboratory workflows to ensure seamless integration and alignment with specific laboratory needs. Consequently, a well-thought-out implementation strategy encompasses careful workflow analysis, software selection, hardware integration, data security and compliance measures, and robust change management strategies, ultimately fostering a more efficient and secure environment in AP laboratories.

In the anatomic pathology laboratory, one of the significant tools driving this revolution is using bar codes in tracking solutions. Bar codes have been used in many other areas of health care facilities, including the blood bank, pharmacy, medical records, materials management, and point-of-care. Barcoding has been used in the clinical pathology laboratory for decades. From this clinical pathology experience, we have learned that it is feasible to have labeling and tracking begin at the time of specimen collection and not just at accessioning, that bar codes support robotics and automation, simplify specimen sharing to perform multiple tests, and can help reduce staffing needs. Furthermore, several clinical pathology laboratory information systems (LIS) have evolved to accommodate foreign (i.e., outside client) bar codes and have shifted toward adopting universal ones.

FutureWise Market Research has published a report that provides an insightful analysis anatomic pathology track and trace solutions market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anatomic pathology track and trace solutions market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher Scientific Inc.
  • Leica Biosystems Nussloch GmbH (Subsidiary of Danaher Corporation)
  • General Data Healthcare Inc.
  • Ventana Medical Systems, Inc.
  • Agilent Technologies, Inc.
  • Sunquest Information Systems, Inc.
  • Cerebrum Corp
  • AP Easy Software Solutions
  • Zebra Technologies Corporation
  • Primera Technology, Inc.
  • LigoLab, LLC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in anatomic pathology track and trace solutions market:

In May 2021-Hologic has received FDA premarket approval for its ThinPrep Genesis™ processor, a device that improves cytology processing and specimen transfer for downstream applications in pathology and laboratory medicine. This approval marks a significant advancement in diagnostic technology, promising enhanced efficiency and accuracy in patient care and diagnostics.

The increasing prevalence and incidence of chronic diseases, such as cancer and cardiovascular diseases, poses significant demand for the anatomic pathology track and trace solutions market. These diseases are setting a substantial burden on healthcare systems globally, creating a need for accurate and timely diagnosis and disease management. Track and trace solutions contribute to the accuracy and reliability of these services by ensuring proper specimen identification, reducing errors, and improving diagnostic accuracy. By implementing track and trace solutions, healthcare providers can effectively track and trace specimens throughout the entire workflow, from collection to analysis, assuring patients receive the appropriate treatment based on accurate diagnosis. Furthermore, high implementation and maintenance costs are expected to obstruct the growth of the anatomic pathology track and trace solution market. A number of end users, essentially small and medium-sized laboratories, seek cost-effectiveness and choose refurbished systems, particularly in developing regions markets. Additionally, the market requires substantial infrastructure, software, and staff training investment. Thus, ongoing maintenance and upgrades can be costly, which may impose a barrier to adoption for some small-scale laboratories.

By Product

  • Software
  • Hardware
    • Printers and Labeling Systems
    • Barcode Scanners and RFID Readers
    • Mobile Computing Systems
  • Consumables
    • Barcode Labels and RFID Tags
    • Slides
    • Specimen Containers, Tissue Cassettes, and Blocks
    • Transport Bags

By Technology

  • Barcode
  • RFID

By Application

  • Slides Tracking
  • Tissue Cassettes and Blocks Tracking
  • Specimen Tracking

By End User

  • Hospital Laboratories
  • Independent and Reference Laboratories
  • Other End Users (Contract Research Organizations, Government-funded Medical Laboratories, and Research Institutes)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The rising incidence of chronic diseases, declining number of pathologists, increasing volume of diagnostic tests in anatomic pathology laboratories, increasing healthcare expenditure, and the presence of key players are some of the significant factors contribute to the growth of the anatomic pathology track and trace solution market in this region. Additionally, the demand for automated labeling systems is being driven in many anatomic pathology laboratories across North America by the need to eliminate specimen identification errors.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anatomic Pathology Track and Trace Solutions Market By Product, By Technology, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anatomic Pathology Track and Trace Solutions Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anatomic Pathology Track and Trace Solutions Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anatomic Pathology Track and Trace Solutions Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anatomic Pathology Track and Trace Solutions Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Software
        2. Hardware
         2.1. Printers and Labeling Systems
         2.2. Barcode Scanners and RFID Readers
         2.3. Mobile Computing Systems
        3. Consumables
         3.1. Barcode Labels and RFID Tags
         3.2. Slides
         3.3. Specimen Containers, Tissue Cassettes, and Blocks
         3.4. Transport Bags

  • 8.   Anatomic Pathology Track and Trace Solutions Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Barcode
        2. RFID

  • 9.   Anatomic Pathology Track and Trace Solutions Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Slides Tracking
        2. Tissue Cassettes and Blocks Tracking
        3. Specimen Tracking

  • 10.   Anatomic Pathology Track and Trace Solutions Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Laboratories
        2. Independent and Reference Laboratories
        3. Other End Users (Contract Research Organizations, Government-funded Medical Laboratories, and Research Institutes)

  • 11.   North America Anatomic Pathology Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Anatomic Pathology Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Anatomic Pathology Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Anatomic Pathology Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Leica Biosystems Nussloch GmbH (Subsidiary of Danaher Corporation)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. General Data Healthcare Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Ventana Medical Systems, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Agilent Technologies, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sunquest Information Systems, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cerebrum Corp
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AP Easy Software Solutions
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Zebra Technologies Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Primera Technology, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. LigoLab, LLC.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients